Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-O-Acetyl-11-hydroxy-beta-boswellic acid is the precursor of 3-O-acetyl-9, 11-dehydro-beta-boswellic acid(a 5-lipoxygenase inhibitor ).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 30,000 |
5 mg | 在庫あり | ¥ 72,000 |
10 mg | 在庫あり | ¥ 114,000 |
25 mg | 在庫あり | ¥ 182,000 |
50 mg | お問い合わせ | ¥ 248,000 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 91,500 |
説明 | 3-O-Acetyl-11-hydroxy-beta-boswellic acid is the precursor of 3-O-acetyl-9, 11-dehydro-beta-boswellic acid(a 5-lipoxygenase inhibitor ). |
In vitro | 4 pentacyclic triterpenoid acids were isolated from Boswellia carterii and identified by NMR and Mass spectroscopic analysis (compounds 1, 3-O-acetyl-9,11-dehydro-β-boswellic acid; 2, 3-O-Acetyl-11-hydroxy-beta-boswellic acid ; 3. 3-O- acetyl-11-keto-β-boswellic acid and 4, 11-keto-β-boswellic acid. Their inhibitory activity on Jack bean urease were evaluated. Docking and pharmacophore analysis using AutoDock 4.2 and Ligandscout 3.03 programs were also performed to explain possible mechanism of interaction between isolated compounds and urease enzyme. It was found that compound 1 has the strongest inhibitory activity against Jack bean urease (IC50 = 6.27 ± 0.03 μM), compared with thiourea as a standard inhibitor (IC50 = 21.1 ± 0.3 μM)[1] |
植物由来 |
分子量 | 514.74 |
分子式 | C32H50O5 |
CAS No. | 146019-25-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (97.14 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-O-Acetyl-11-hydroxy-beta-boswellic acid 146019-25-2 Metabolism Lipoxygenase 3OAcetyl11hydroxybetaboswellic acid LOX Inhibitor 3-O-Acetyl-11-hydroxy-b-boswellic acid 3-O-Acetyl-11-hydroxy-β-boswellic acid 3 O Acetyl 11 hydroxy beta boswellic acid inhibit inhibitor